))
Neuroendocrine Tumors (NETs): Breakthroughs in Diagnosis & Treatment
Manage episode 492349738 series 3649266
Content provided by vpod.ai. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by vpod.ai or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Welcome to vpod.ai’s The Deep Dive, proudly sponsored by StoneFly. In this episode, we explore the complex, often misunderstood world of neuroendocrine tumors (NETs)—from silent symptoms to cutting-edge treatments revolutionizing outcomes.
You'll learn:
- What NETs are, where they originate, and why the term “carcinoid” is outdated
- How carcinoid syndrome causes symptoms like flushing, diarrhea, and heart issues
- The step-by-step diagnostic process, from biomarkers to biopsy
- Why surgery remains vital—and what’s next when surgery isn’t enough
- Advances in somatostatin analogs, Everolimus, and targeted therapies
- Game-changers like CAR-T cell therapy, new immunotherapy combinations, and anti-angiogenesis drugs
- How the latest FDA approvals are reshaping care for advanced and aggressive NETs
This is the frontline of rare cancer research—where collaboration, innovation, and precision medicine are making a real difference.
127 episodes
Share
